These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18398949)

  • 1. The time has come to include assessment of radiographic progression in juvenile idiopathic arthritis clinical trials.
    Ravelli A
    J Rheumatol; 2008 Apr; 35(4):553-7. PubMed ID: 18398949
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiologic Improvement of juvenile idiopathic arthritis-enthesitis-related arthritis following anti-tumor necrosis factor-alpha blockade with etanercept.
    Tse SM; Laxer RM; Babyn PS; Doria AS
    J Rheumatol; 2006 Jun; 33(6):1186-8. PubMed ID: 16755667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiographic improvement of damaged large joints in children with systemic juvenile idiopathic arthritis following tocilizumab treatment.
    Inaba Y; Ozawa R; Imagawa T; Mori M; Hara Y; Miyamae T; Aoki C; Saito T; Yokota S
    Ann Rheum Dis; 2011 Sep; 70(9):1693-5. PubMed ID: 21402562
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiographic and clinical outcome in early juvenile rheumatoid arthritis and juvenile spondyloarthropathy: a 3-year prospective study.
    Selvaag AM; Flatø B; Dale K; Lien G; Vinje O; Smerdel-Ramoya A; Førre Ø
    J Rheumatol; 2006 Jul; 33(7):1382-91. PubMed ID: 16758503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrepancy between clinical and radiological responses to tocilizumab treatment in patients with systemic-onset juvenile idiopathic arthritis.
    Aoki C; Inaba Y; Choe H; Kaneko U; Hara R; Miyamae T; Imagawa T; Mori M; Oba MS; Yokota S; Saito T
    J Rheumatol; 2014 Jun; 41(6):1171-7. PubMed ID: 24786929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year outcome of juvenile idiopathic arthritis in current daily practice: what can we tell our patients?
    Anink J; Dolman KM; Merlijn van den Berg J; van Veenendaal M; Kuijpers TW; van Rossum MA
    Clin Exp Rheumatol; 2012; 30(6):972-8. PubMed ID: 23190600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiologic features in juvenile idiopathic arthritis: a first step in the development of a standardized assessment method.
    van Rossum MA; Zwinderman AH; Boers M; Dijkmans BA; van Soesbergen RM; Fiselier TJ; Franssen MJ; ten Cate R; van Suijlekom-Smit LW; Wulffraat NM; Kuis W; van Luijk WH; Oostveen JC; Dijkstra PF;
    Arthritis Rheum; 2003 Feb; 48(2):507-15. PubMed ID: 12571861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiologic progression in patients with juvenile chronic arthritis treated with methotrexate.
    Ravelli A; Viola S; Ramenghi B; Beluffi G; Zonta LA; Martini A
    J Pediatr; 1998 Aug; 133(2):262-5. PubMed ID: 9709717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?
    Nigrovic PA
    Arthritis Rheumatol; 2014 Jun; 66(6):1405-13. PubMed ID: 24623686
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of the Sharp and Larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritis.
    Rossi F; Di Dia F; Galipò O; Pistorio A; Valle M; Magni-Manzoni S; Ruperto N; Tomà P; Martini A; Ravelli A
    Arthritis Rheum; 2006 Oct; 55(5):717-23. PubMed ID: 17013855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab for systemic onset juvenile idiopathic arthritis: experience in 3 children.
    Billiau AD; Cornillie F; Wouters C
    J Rheumatol; 2002 May; 29(5):1111-4. PubMed ID: 12022340
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel treatment options for juvenile idiopathic arthritis.
    Steigerwald KA; Ilowite NT
    Expert Rev Clin Pharmacol; 2015; 8(5):559-73. PubMed ID: 26294075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What matters most for patients, parents, and clinicians in the course of juvenile idiopathic arthritis? A qualitative study.
    Guzman J; Gómez-Ramírez O; Jurencak R; Shiff NJ; Berard RA; Duffy CM; Oen K; Petty RE; Benseler SM; Brant R; Tucker LB
    J Rheumatol; 2014 Nov; 41(11):2260-9. PubMed ID: 25225279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward a treat-to-target approach in the management of juvenile idiopathic arthritis.
    Consolaro A; Negro G; Lanni S; Solari N; Martini A; Ravelli A
    Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S157-62. PubMed ID: 23072725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Juvenile Idiopathic Arthritis 2015: A Position Statement from the Pediatric Committee of the Canadian Rheumatology Association.
    Cellucci T; Guzman J; Petty RE; Batthish M; Benseler SM; Ellsworth JE; Houghton KM; LeBLANC CM; Huber AM; Luca N; Schmeling H; Shiff NJ; Soon GS; Tse SM;
    J Rheumatol; 2016 Oct; 43(10):1773-1776. PubMed ID: 27698103
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation between juvenile idiopathic arthritis activity and damage measures in early, advanced, and longstanding disease.
    Palmisani E; Solari N; Magni-Manzoni S; Pistorio A; Labò E; Panigada S; Martini A; Ravelli A
    Arthritis Rheum; 2006 Dec; 55(6):843-9. PubMed ID: 17139659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in health-related quality of life for children with juvenile idiopathic arthritis after start of treatment with etanercept.
    Klotsche J; Minden K; Thon A; Ganser G; Urban A; Horneff G
    Arthritis Care Res (Hoboken); 2014 Feb; 66(2):253-62. PubMed ID: 23983081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Description of active joint count trajectories in juvenile idiopathic arthritis.
    Berard RA; Tomlinson G; Li X; Oen K; Rosenberg AM; Feldman BM; Yeung RS; Bombardier C
    J Rheumatol; 2014 Dec; 41(12):2466-73. PubMed ID: 25274882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement.
    Woo P; Wilkinson N; Prieur AM; Southwood T; Leone V; Livermore P; Wythe H; Thomson D; Kishimoto T
    Arthritis Res Ther; 2005; 7(6):R1281-8. PubMed ID: 16277681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiographic progression in children with polyarticular juvenile rheumatoid arthritis: a pilot study.
    Mason T; Reed AM; Nelson AM; Thomas KB
    Ann Rheum Dis; 2005 Mar; 64(3):491-3. PubMed ID: 15708901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.